Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Ladewig

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 15, 2005
Prostaglandin E1 infusion therapy in dry age-related macular degenerationM S Ladewig, K Ladewig, M Güner, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|July 5, 2006
[Ocular manifestations and surgical results in patients with Marfan syndrome]M S Ladewig, P N Robinson, L M Neumann, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 10, 2006
[Pseudoxanthoma elasticum]M S Ladewig, C Götting, C Szliska, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 10, 2006
[Intravitreal bevacizumab for neovascular age-related macular degeneration]M S Ladewig, F Ziemssen, G Jaissle, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 15, 2005
Prostaglandin E1 infusion therapy in dry age-related macular degenerationM S Ladewig, K Ladewig, M Güner, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|July 5, 2006
[Ocular manifestations and surgical results in patients with Marfan syndrome]M S Ladewig, P N Robinson, L M Neumann, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 10, 2006
[Pseudoxanthoma elasticum]M S Ladewig, C Götting, C Szliska, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 10, 2006
[Intravitreal bevacizumab for neovascular age-related macular degeneration]M S Ladewig, F Ziemssen, G Jaissle, et al.
Pageof 1